The FDA just approved the first once-daily oral PCSK9 pill, and five major stocks now sit in the crosshairs. Not all of them ...

Another biotech is squeezing into the crowded IPO waiting room just in time for the weekend. | Another biotech is squeezing ...

Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection ...

Antibody-drug conjugates from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck & Co. and GSK, delivered ...

Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping reduce costs and improve access to ...

Healthy eaters who never smoked are getting lung cancer—and scientists think pesticides on produce may be why.

Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark Global Fund”. A copy of the letter ...

The trial reported that none of the 13 patients treated so far have experienced serious adverse events related to ENV-105.

Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") .  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 ...

Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark Global Fund”. A copy of the letter ...

See which leaders are on the move across the pharma, biotech and medical marketing industries.

On Friday, June 27, the American Lung Association honored AstraZeneca with the Outstanding Corporate Partner Award at its ...